127 related articles for article (PubMed ID: 36646396)
1. Perioperative escape from dormancy of spontaneous micro-metastases: A role for malignant secretion of IL-6, IL-8, and VEGF, through adrenergic and prostaglandin signaling.
Haldar R; Berger LS; Rossenne E; Radin A; Eckerling A; Sandbank E; Sloan EK; Cole SW; Ben-Eliyahu S
Brain Behav Immun; 2023 Mar; 109():175-187. PubMed ID: 36646396
[TBL] [Abstract][Full Text] [Related]
2. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
Glasner A; Avraham R; Rosenne E; Benish M; Zmora O; Shemer S; Meiboom H; Ben-Eliyahu S
J Immunol; 2010 Mar; 184(5):2449-57. PubMed ID: 20124103
[TBL] [Abstract][Full Text] [Related]
3. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract][Full Text] [Related]
4. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.
Sorski L; Melamed R; Matzner P; Lavon H; Shaashua L; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2016 Nov; 58():91-98. PubMed ID: 27235931
[TBL] [Abstract][Full Text] [Related]
5. "Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.
Tennakoon G; Auer R
Brain Behav Immun; 2023 Jul; 111():247-248. PubMed ID: 37127226
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome.
Shaashua L; Eckerling A; Israeli B; Yanovich G; Rosenne E; Fichman-Horn S; Ben Zvi I; Sorski L; Haldar R; Satchi-Fainaro R; Geiger T; Sloan EK; Ben-Eliyahu S
BMC Biol; 2020 Nov; 18(1):163. PubMed ID: 33158447
[TBL] [Abstract][Full Text] [Related]
7. The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.
Hazut O; Shaashua L; Benish M; Levi B; Sorski L; Benjamin B; Hoffman A; Zmora O; Ben-Eliyahu S
Int J Clin Pharmacol Ther; 2011 Sep; 49(9):545-54. PubMed ID: 21888867
[TBL] [Abstract][Full Text] [Related]
8. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.
Benish M; Bartal I; Goldfarb Y; Levi B; Avraham R; Raz A; Ben-Eliyahu S
Ann Surg Oncol; 2008 Jul; 15(7):2042-52. PubMed ID: 18398660
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta blocker combined with COX-2 inhibitor on colonic anastomosis in rats.
Benjamin B; Hazut O; Shaashua L; Benish M; Zmora N; Barshack I; Hoffman A; Ben-Eliyahu S; Zmora O
Int J Colorectal Dis; 2010 Dec; 25(12):1459-64. PubMed ID: 20556396
[TBL] [Abstract][Full Text] [Related]
11. Perioperative COX2 and β-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial.
Haldar R; Ricon-Becker I; Radin A; Gutman M; Cole SW; Zmora O; Ben-Eliyahu S
Cancer; 2020 Sep; 126(17):3991-4001. PubMed ID: 32533792
[TBL] [Abstract][Full Text] [Related]
12. Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.
Shaashua L; Shabat-Simon M; Haldar R; Matzner P; Zmora O; Shabtai M; Sharon E; Allweis T; Barshack I; Hayman L; Arevalo J; Ma J; Horowitz M; Cole S; Ben-Eliyahu S
Clin Cancer Res; 2017 Aug; 23(16):4651-4661. PubMed ID: 28490464
[No Abstract] [Full Text] [Related]
13. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
14. The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
Rivero EM; Piñero CP; Gargiulo L; Entschladen F; Zänker K; Bruzzone A; Lüthy IA
Curr Cancer Drug Targets; 2017; 17(8):756-766. PubMed ID: 28359245
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model.
Na YR; Yoon YN; Son DI; Seok SH
PLoS One; 2013; 8(5):e63451. PubMed ID: 23667623
[TBL] [Abstract][Full Text] [Related]
16. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.
Chen WS; Wei SJ; Liu JM; Hsiao M; Kou-Lin J; Yang WK
Int J Cancer; 2001 Mar; 91(6):894-9. PubMed ID: 11275997
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
Wakabayashi H; Hamaguchi T; Nagao N; Kato S; Iino T; Nakamura T; Sudo A
Breast Cancer; 2018 Sep; 25(5):566-574. PubMed ID: 29557068
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
Matsunaga N; Yamada N; Ohira M; Tachimori A; Nishiguchi Y; Nishino H; Seki S; Hirakawa K
Oncol Rep; 2004 Jan; 11(1):167-71. PubMed ID: 14654921
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
[TBL] [Abstract][Full Text] [Related]
20. Deleterious synergistic effects of distress and surgery on cancer metastasis: Abolishment through an integrated perioperative immune-stimulating stress-inflammatory-reducing intervention.
Matzner P; Sorski L; Haldar R; Shaashua L; Benbenishty A; Lavon H; Azan Y; Sandbank E; Melamed R; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2019 Aug; 80():170-178. PubMed ID: 30851377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
